SOMAXON PHARMACEUTICALS, INC.

Profile

Company Names

SOMAXON PHARMACEUTICALS, INC.

Addresses

420 STEVENS AVENUE, SUITE 210, SOLANA BEACH, CA 92075

Phone Numbers

(858) 480-0400

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$5,999,990.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2009-07-08 
$5,999,990.00 
$5,999,990.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TERRELL 
A. 
COBB 
DIRECTOR
SOMAXON PHARMACEUTICALS, INC.
BRIAN 
T. 
DORSEY 
EXECUTIVE OFFICER
SOMAXON PHARMACEUTICALS, INC.
MICHAEL 
L. 
EAGLE 
DIRECTOR
SOMAXON PHARMACEUTICALS, INC.   |  HANSEN MEDICAL INC
DAVID 
F. 
HALE 
DIRECTOR
SKINMEDICA INC   |  SOMAXON PHARMACEUTICALS, INC.   |  NEURELIS, INC.   |  RIDGE DIAGNOSTICS, INC.   |  CONATUS PHARMACEUTICALS INC   |  AGILITY CLINICAL, INC.   |  COLORESCIENCE INC   |  TOKALAS, INC.   |  RECROS MEDICA, INC.   |  IDUN PHARMACEUTICALS INC   |  MDREJUVENA, INC.   |  DERMATA THERAPEUTICS, LLC   |  ONCTERNAL THERAPEUTICS, INC.   |  ADIGICA HEALTH, INC.   |  NEURANA PHARMACEUTICALS, INC.   |  CLARIFY MEDICAL, INC.   |  ONCTERNAL THERAPEUTICS, INC.
ERLE 
T. 
MAST 
DIRECTOR
ZOGENIX INC   |  CLOVIS ONCOLOGY, INC.   |  SOMAXON PHARMACEUTICALS, INC.
MATTHEW 
W. 
ONAITIS 
EXECUTIVE OFFICER
SOMAXON PHARMACEUTICALS, INC.
RICHARD 
W. 
PASCOE 
EXECUTIVE OFFICER, DIRECTOR
SOMAXON PHARMACEUTICALS, INC.   |  KEMPHARM, INC   |  APRICUS BIOSCIENCES, INC.   |  SEELOS THERAPEUTICS, INC.   |  HISTOGEN INC.
JEFFREY 
W. 
RASER 
EXECUTIVE OFFICER
SOMAXON PHARMACEUTICALS, INC.   |  ORPRO THERAPEUTICS, INC.
JESSE 
I. 
TREU 
DIRECTOR
ALTEA THERAPEUTICS CORP   |  DP VIII ASSOCIATES, L.P.   |  DOMAIN PARTNERS VIII, L.P.   |  SOMAXON PHARMACEUTICALS, INC.   |  COLUCID PHARMACEUTICALS, INC.   |  VERACYTE, INC.   |  ALDEYRA THERAPEUTICS, INC.
KURT 
 
VON EMSTER 
DIRECTOR
METABOLEX, INC.   |  SOMAXON PHARMACEUTICALS, INC.   |  VENBIO SELECT FUND LTD.   |  VENBIO SELECT FUND LLC   |  VENBIO GLOBAL STRATEGIC FUND, L.P.   |  CYMABAY THERAPEUTICS, INC.   |  SUTROVAX, INC.   |  CRISPR THERAPEUTICS AG   |  ABINGWORTH BIOVENTURES VII LP   |  ATTENUA, INC.   |  ORBUS THERAPEUTICS, INC.   |  VERA THERAPEUTICS, INC.   |  IAMBIC THERAPEUTICS, INC.
KURT 
C. 
WHEELER 
DIRECTOR
ZOGENIX INC   |  SOMAXON PHARMACEUTICALS, INC.   |  CLARUS LIFESCIENCES III, L.P.   |  CLARUS DEFINED EXIT I, L.P.   |  CLARUS DE II, L.P.   |  CLARUS IV-D, L.P.   |  CLARUS IV-C, L.P.   |  CLARUS IV-B, L.P.   |  CLARUS IV-A, L.P.
THOMAS 
G. 
WIGGANS 
DIRECTOR
SOMAXON PHARMACEUTICALS, INC.   |  DERMIRA, INC.   |  ANNEXON, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2009-07-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2009-07-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#